An audit of disseminated intravascular coagulation screen requests at an academic hospital laboratory in central South Africa.


Journal

International journal of laboratory hematology
ISSN: 1751-553X
Titre abrégé: Int J Lab Hematol
Pays: England
ID NLM: 101300213

Informations de publication

Date de publication:
Oct 2021
Historique:
revised: 17 12 2020
received: 06 08 2020
accepted: 21 12 2020
pubmed: 2 2 2021
medline: 30 11 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Disseminated intravascular coagulation (DIC) is a feared complication of various systemic illnesses. We aimed to evaluate the laboratory requesting practices of clinicians, especially concerning the laboratory parameters, included in the International Society of Thrombosis and Haemostasis (ISTH) DIC score. A retrospective descriptive study was performed and included data from DIC screen requests analysed at Universitas National Health Laboratory Service (NHLS) laboratory, Bloemfontein, South Africa, for one calendar year. Laboratory request forms were analysed, recording the pretest diagnosis and whether the diagnosis was associated with DIC. Parameters of the DIC screen, prothrombin time, activated partial thromboplastin time, thrombin time, d-dimer and fibrinogen were used to calculate the ITSH DIC score and diagnose heparin contamination. The platelet count, currently not part of the DIC screen test set, was also recorded. A total of 778 DIC screen requests were processed. One hundred and eighty-three requests were excluded due to laboratory-defined rejection criteria, heparin contamination or for lacking an ISTH score parameter. Of the remaining 595 complete requests, 283 (47.7%) were laboratory-defined overt DIC. The pretest diagnosis was not predictive of either a positive or negative finding of overt DIC. The contribution of fibrinogen to assigning overt DIC was questionable. The number of DIC screen requests received highlights the need for laboratory evidence of DIC. To improve laboratory DIC testing, the authors suggest critical evaluation of the contribution of the pretest diagnosis and fibrinogen in a prospective study and adding the platelet count in our local DIC test set.

Identifiants

pubmed: 33522121
doi: 10.1111/ijlh.13461
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0
Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1174-1180

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2(1):15. https://doi.org/10.1186/2052-0492-2-15
Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42. https://doi.org/10.1186/s12959-016-0117-x
Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost. 2010;36(4):458-467. https://doi.org/10.1055/s-0030-1254055
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327-1330.
Key N, Makris M, O'Shaughnessy D, Lillicrap D, eds. Practical Hemostasis and Thrombosis (2nd edn). Hoboken, NJ: Wiley-Blackwell; 2011.
Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res. 2009;124(5):608-613. https://doi.org/10.1016/j.thromres.2009.06.034
Wada H, Asakura H, Okamoto K, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res. 2010;125(1):6-11. https://doi.org/10.1016/j.thromres.2009.08.017
Umemura Y, Yamakawa K, Hayakawa M, Hamasaki T, Fujimi S. Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan. Thromb Res. 2018;161:60-66. https://doi.org/10.1016/j.thromres.2017.11.023
Toh CH, Alhamdi Y, Abrams ST. Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation [published correction appears in Ann Lab Med. 2017 Jan; 37(1):95]. Ann Lab Med. 2016;36(6):505-512. https://doi.org/10.3343/alm.2016.36.6.505
Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11:761-767. https://doi.org/10.1111/jth.12155
Toh CH, Hoots WK. SSC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604-606. https://doi.org/10.1111/j.1538-7836.2007.02313.x
Soundar EP, Jariwala P, Nguyen TC, Eldin KW, Teruya J. Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. Am J Clin Pathol. 2013;139(6):812-816. https://doi.org/10.1309/AJCPO64IWNLYCVVB
Laffan MA, Manning RA. In: Bain BJ, Bates I, Laffan MA ed. Investigation of Haemostasis, vol. 18. Amsterdam, Nederlands; Elsevier: Dacie and Lewis Practical Haematology (Twelfth Edition); 2017:366-409.
Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate Haematology. Hoboken, NJ: Wiley; 2015.
Dikmen ZG, Pinar A, Akbiyik F. Specimen rejection in laboratory medicine: Necessary for patient safety? Biochem Med (Zagreb). 2015;25(3):377-385. https://doi.org/10.11613/BM.2015.037
Coetzee M, Joubert G, Swart M, Streicher A, Kruger M, Koekemoer H. An audit of the completion of bone marrow specimen request forms at an academic laboratory. Medical Technology SA. 2017;31:1-4.
Luo L, Wu Y, Niu T, et al. A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation. Thromb Res. 2019;173:131-140. https://doi.org/10.1016/j.thromres.2018.11.022
Ding R, Wang Z, Lin Y, Liu B, Zhang Z, Ma X. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study. Blood Coagul Fibrinolysis. 2018;29(6):551-558. https://doi.org/10.1097/MBC.0000000000000755
Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32(12):2416-2421. https://doi.org/10.1097/01.ccm.0000147769.07699.e3
Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med. 2000;28(6):1777-1780. https://doi.org/10.1097/00003246-200006000-00013
Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol. 2018;11(8):663-672. https://doi.org/10.1080/17474086.2018.1500173

Auteurs

Leriska Haupt (L)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
National Health Laboratory Service, Universitas Academic Laboratory, Bloemfontein, South Africa.

Mario Vieira (M)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Hanti Brits (H)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Jaco de Beer (J)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Etienne Erasmus (E)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Wian Esterhuyse (W)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Ruben Fraser (R)

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Gina Joubert (G)

Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH